Prof. Dr. Oliver Distler is Professor of Rheumatology at the University of Zurich and Head of the Department of Rheumatology at University Hospital Zurich in Switzerland. He is also Head of the Business Division of Traumatology-Dermatology-Rheumatology-Plastic Surgery and Emergency Medicine at the University Hospital Zurich.
Prof. Dr. Distler earned his medical degree from the University of Erlangen in Germany in 1997. Subsequently, he completed his internship in internal medicine at Bamberg Hospital and his residency and fellowship at the University Hospital of Regensburg, both in Germany. Prof. Dr. Distler then did a postdoctoral fellowship in the Center of Experimental Rheumatology at the University of Zurich and additional fellowships in the Departments of Rheumatology and Clinical Immunology at University Hospital Zurich.
Prof. Dr. Distler’s research focuses on molecular mechanisms of inflammatory rheumatic diseases, the validation of biomarkers, the identification and characterization of animal models, and the design of proof-of-concept and phase 2/3 trials. He has authored over 250 papers on these topics, and he is a member of the editorial boards of Lancet Rheumatology and Annals of the Rheumatic Diseases. Prof. Dr. Distler has been a board member and chairman of several academic initiatives, such as the Scleroderma Clinical Trial Consortium and the European Scleroderma Trials and Research Group (EUSTAR). He is currently Executive Chair of the EULAR-associated FOREUM Foundation.
[International Symposium] New Horizon of Systemic Sclerosis